CD8+ T cells are known to inhibit tumor angiogenesis by secreting IFN-γ [19, 34], whereas the presence of CD25+/FOXP3+ tumor-infiltrating lymphocytes reportedly correlates with promoting intratumoral angiogenesis in multiple sorts of cancer including endometrial cancer [14–16]. The gene discussed is IFNG; the disease is cancer.